United Therapeutics (UTHR) Minority Interest (2009 - 2016)

United Therapeutics (UTHR) has 8 years of Minority Interest data on file, last reported at $10.9 million in Q4 2016.

• For the quarter ending Q4 2016, Minority Interest changed 0.0% year-over-year to $10.9 million; the trailing twelve-month figure through Dec 2016 stood at $10.9 million (changed 0.0% YoY), and the FY2016 full-year result was $10.9 million, changed 0.0% from the prior year.
• Minority Interest held at $10.9 million in Q4 2016, from $10.9 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $10.9 million in Q4 2015 to a low of $10.9 million in Q1 2012.
• A 5-year average of $10.9 million and a median of $10.9 million in 2012 frame the typical range for Minority Interest.
• Across the five-year window, Minority Interest changed 0.0% in 2012 and increased 0.17% in 2015, its largest moves.
• Tracing UTHR's Minority Interest over 5 years: stood at $10.9 million in 2012, then changed by 0.0% to $10.9 million in 2013, then changed by 0.0% to $10.9 million in 2014, then grew by 0.17% to $10.9 million in 2015, then changed by 0.0% to $10.9 million in 2016.
• Business Quant data shows UTHR's Minority Interest at $10.9 million in Q4 2016, $10.9 million in Q4 2015, and $10.9 million in Q3 2015.